XML 135 R114.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Investments in Non-consolidated Companies - Summary of Investments in Non-consolidated Companies (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of changes in investments in subsidiaries joint ventures and associates [abstract]      
At the beginning of the year $ 1,383,774 $ 957,352  
Translation differences 7,336 (11,085) $ (31,977)
Equity in earnings of non-consolidated companies 242,743 512,591  
Impairment loss in non-consolidated companies [1] (34,041)  
Dividends and distributions declared [2] (64,189) (78,926)  
Increase in equity reserves and others 5,023 3,842  
At the end of the year $ 1,540,646 $ 1,383,774 $ 957,352
[1] Includes an impairment of $19.1 million related to the investment in Usiminas and $14.9 million related to the joint venture with PAO Severstal (“Severstal”). For more information see note 36.
[2] Related to Ternium and Usiminas. During 2022 and 2021 $66.2 million and$75.9 million respectively were collected.